1 Gandhi NA, Bennett BL, Graham NMH, Pirozzi G, Stahl N, Yancopoulos GD. Targeting key proximal drivers of type 2 inflammation in disease. Nat Rev Drug Discov. 2016; 15(1): 35-50.
2 Gandhi NA, Pirozzi G, Graham NM. Commonality of the IL-4/IL-13 pathway in atopic diseases. Expert review of clinical immunology. 2017 May 4;13(5):425-37.
3 Cherwinski, H. M., Schumacher, J. H., Brown, K. D., & Mosmann, T. R. (1987). Two types of mouse helper T cell clone. III. Further differences in lymphokine synthesis between Th1 and Th2 clones revealed by RNA hybridization, functionally monospecific bioassays, and monoclonal antibodies. The Journal of experimental medicine, 166(5), 1229-1244
4 Snapper CM, Finkelman FD, Paul WE. Regulation of IgG1 and IgE production by interleukin 4. Immunological reviews. 1988 Apr 1;102(1):51-75.
5 Mosmann, T. R. & Coffman, R. L. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 7, 145–173 (1989).
6Ray, Anuradha, Timothy B. Oriss, and Sally E. Wenzel. "Emerging molecular phenotypes of asthma." American Journal of Physiology-Lung Cellular and Molecular Physiology 308.2 (2015): L130-L140.
7 Muraro, Antonella, et al. "Precision medicine in patients with allergic diseases: airway diseases and atopic dermatitis—PRACTALL document of the European Academy of Allergy and Clinical Immunology and the American Academy of Allergy, Asthma & Immunology." Journal of allergy and clinical immunology 137.5 (2016): 1347-1358.
8 Matsusaka, Masako, et al. "Subphenotypes of type 2 severe asthma in adults." The Journal of Allergy and Clinical Immunology: In Practice 6.1 (2018): 274-276.
9 Khan, Asif et al. “Type 2 inflammation-related comorbidities among patients with asthma, chronic rhinosinusitis with nasal polyps, and atopic dermatitis.” European Respiratory Journal 2020; 56: Suppl. 64, 232.
10 Silverberg, Jonathan I. Comorbidities and the impact of atopic dermatitis. Annals of Allergy, Asthma & Immunology. 2019.
11 Bieber T. Mechanisms of disease: atopic dermatitis. N Engl J Med. 2008; 358:1483-9.
12 Gittler, J. K. et al. (2012). Progressive activation of T(H)2/T(H)22 cytokines and selective epidermal proteins characterizes acute and chronic atopic dermatitis. The Journal of allergy and clinical immunology, 130(6), 1344–1354.
13 Bjermer L. Time for a paradigm shift in asthma treatment: from relieving bronchospasm to controlling systemic inflammation. Journal of Allergy and clinical Immunology. 2007 Dec 1;120(6):1269-75.
14 Fokkens WJ, Lund VJ, Hopkins C, Hellings PW, Kern R, Reitsma S, Toppila-Salmi S, Bernal-Sprekelsen M, Mullol J, Alobid I, Anselmo-Lima WT. European position paper on rhinosinusitis and nasal polyps 2020. Rhinology. 2020;58:I-+.
15 Huang E, Ong PY. Severe atopic dermatitis in children. Current allergy and asthma reports. 2018 Jun;18(6):1-8.
16 von Mutius E. The burden of childhood asthma. Archives of disease in childhood. 2000; 82(suppl 2):ii2-ii5.
17 Menard‐Katcher P, Marks KL, Liacouras CA, Spergel JM, Yang YX, Falk GW. The natural history of eosinophilic oesophagitis in the transition from childhood to adulthood. Alimentary pharmacology & therapeutics. 2013 Jan;37(1):114-21.
18 Zuberbier T, Orlow SJ, Paller AS, et al. Patient perspectives on the management of atopic dermatitis. J Allergy Clin Immunol. 2006;118(1):226-232.
19 Silverberg JI, Lei D, Yousaf M, Janmohamed SR, Vakharia PP, Chopra R, Chavda R, Gabriel S, Patel KR, Singam V, Kantor R. Association of itch triggers with atopic dermatitis severity and course in adults. Annals of Allergy, Asthma & Immunology. 2020 Nov 1;125(5):552-9.
20 Lucendo AJ, et al. Guidelines on eosinophilic esophagitis: evidence-based statements and recommendations for diagnosis and management in children and adults. United European Gastroenterol J. 2017;5(3):335-358.
21 Global Initiative for Asthma (GINA). Global Strategy for Asthma Management and Prevention. 2022. Available at: https://ginasthma.org/gina-reports/. Accessed: July 2022
22 Sidbury R, Tom WL, Bergman JN, Cooper KD, Silverman RA, Berger TG, Chamlin SL, Cohen DE, Cordoro KM, Davis DM, Feldman SR. Guidelines of care for the management of atopic dermatitis: Section 4. Prevention of disease flares and use of adjunctive therapies and approaches. Journal of the American Academy of Dermatology. 2014 Dec 1;71(6):1218-33.
23 European Respiratory Society. European Lung White Book, Chapter 2: The economic burden of lung disease. Available at: https://www.erswhitebook.org/chapters/the-economic-burden-of-lung-disease/. Accessed: June 2021.
24 Eckert L, Gupta S, Gadkari A, Mahajan P, Gelfand JM. Burden of illness in adults with atopic dermatitis: Analysis of National Health and Wellness Survey data from France, Germany, Italy, Spain, and the United Kingdom. J Am Acad Dermatol. 2019;81(1):187-195.
25 Mukkada V, et al. Health-Related Quality of Life and Costs Associated With Eosinophilic Esophagitis: A Systematic Review. Clin Gastroenterol Hepatol. 2018;16(4):495-503.
26 Milton B et al. The social and economic consequences of childhood asthma across the lifecourse: a systematic review. Child: care, health and development. 2004 Nov;30(6):711-28.
27 Daugherty, Jonas, et al. "The impact of long-term systemic glucocorticoid use in severe asthma: a UK retrospective cohort analysis." Journal of Asthma 55.6 (2018): 651-658.
28 Hirano I, Chan ES, Rank MA, Sharaf RN, Stollman NH, Stukus DR, Wang K, Greenhawt M, Falck-Ytter YT, Chachu KA, Day L. AGA institute and the joint task force on allergy-immunology practice parameters clinical guidelines for the management of eosinophilic esophagitis. Gastroenterology. 2020 May 1;158(6):1776-86.
29 Sidbury R, Davis DM, Cohen DE, Cordoro KM, Berger TG, Bergman JN, Chamlin SL, Cooper KD, Feldman SR, Hanifin JM, Krol A. Guidelines of care for the management of atopic dermatitis: section 3. Management and treatment with phototherapy and systemic agents. Journal of the American Academy of Dermatology. 2014 Aug 1;71(2):327-49.
30 Menzies-Gow A, Canonica GW, Winders TA, de Sousa JC, Upham JW, Fink-Wagner AH. A charter to improve patient care in severe asthma. Advances in therapy. 2018 Oct;35(10):1485-96.
31 Staikuniene J, et al. Association of chronic rhinosinusitis with nasal polyps and asthma: clinical and radiological features, allergy and inflammation markers. Medicina (Kaunas) 2008; 44(4):257-265.
32 Liu, Jing Nan, et al. The prevalence of serum specific IgE to superantigens in asthma and allergic rhinitis patients. Allergy, Asthma & Immunology Research. 2014;6(3):263-266.
33 Schleimer, Robert P., and Sergejs Berdnikovs. Etiology of epithelial barrier dysfunction in patients with type 2 inflammatory diseases. Journal of Allergy and Clinical Immunology. 2017;139(6):1752-1761.
34 Sugita K, Kabashima K. Tight junctions in the development of asthma, chronic rhinosinusitis, atopic dermatitis, eosinophilic esophagitis, and inflammatory bowel diseases. Journal of leukocyte biology. 2020 May;107(5):749-62.
35 Eichenfield, Lawrence F., et al. "Guidelines of care for the management of atopic dermatitis: section 1. Diagnosis and assessment of atopic dermatitis." Journal of the American Academy of Dermatology 70.2 (2014): 338-351
36 National Institutes of Health (NIH). Health Topics: Atopic Dermatitis. Available at: https://www.niams.nih.gov/health-topics/atopic-dermatitis. Last accessed June 2021.
37 Nordin S, Hedén Blomqvist E, Olsson P, Stjärne P, Ehnhage A, NAF2S2 Study Group. Effects of smell loss on daily life and adopted coping strategies in patients with nasal polyposis with asthma. Acta oto-laryngologica. 2011 Aug 1;131(8):826-32.
38 Wang R, Hirano I, Doerfler B, Zalewski A, Gonsalves N, Taft T. Assessing adherence and barriers to long-term elimination diet therapy in adults with eosinophilic esophagitis. Digestive diseases and sciences. 2018 Jul;63(7):1756-62.
39 Prussin C, Lee J, Foster B. Eosinophilic gastrointestinal disease and peanut allergy are alternatively associated with IL-5+ and IL-5− TH2 responses. Journal of allergy and clinical immunology. 2009 Dec 1;124(6):1326-32.
40 Mayo Clinic. Peanut Allergy. Available at: https://www.mayoclinic.org/diseases-conditions/peanut-allergy/symptoms-causes/syc-20376175. Accessed June 2021.
41 Seys, Sven F., et al. "Cluster analysis of sputum cytokine-high profiles reveals diversity in T (h) 2-high asthma patients." Respiratory research 18.1 (2017): 1-10.
42 Jackson DJ, Aljamil N, Roxas C, et al. The ‘T2-low’ asthma phenotype: could it just be T2-high asthma treated with corticosteroids? Thorax. 2018;73(suppl 4):A124-A125
43 M. Suárez-Fariñas, N. Dhingra and J. Gittler, “Intrinsic atopic dermatitis shows similar TH2 and higher TH17 immune activation compared with extrinsic atopic dermatitis,” Journal of Allergy and Clinical Immunology, vol. 132, no. 2, pp. 361-70, 2013.
44 M. Chaaban, E. M. Walsh and B. A. Woodworth, “Epidemiology and differential diagnosis of nasal polyps.,” American Journal of Rhinology & Allergy, vol. 27, no. 6, pp. 473-478, 2013.
45 Chehade M, et al. Phenotypic Characterization of Eosinophilic Esophagitis in a Large Multicenter Patient Population from the Consortium for Food Allergy Research. J Allergy Clin Immunol Pract. 2018;6(5):1534-1544.